avzivi

Generic: bevacizumab-tnjn

Labeler: bio-thera solutions, ltd.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name avzivi
Generic Name bevacizumab-tnjn
Labeler bio-thera solutions, ltd.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

bevacizumab-tnjn 400 mg/16mL

Manufacturer
Bio-Thera Solutions, Ltd.

Identifiers & Regulatory

Product NDC 82143-002
Product ID 82143-002_3fff12d3-d86b-14e4-e063-6294a90a122e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761198
Listing Expiration 2026-12-31
Marketing Start 2025-01-01

Pharmacologic Class

Classes
vascular endothelial growth factor inhibitor [epc] vascular endothelial growth factor inhibitors [moa] vascular endothelial growth factor-directed antibody interactions [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 82143002
Hyphenated Format 82143-002

Supplemental Identifiers

RxCUI
2700735 2700742 2700744 2700745
UNII
2S9ZZM9Q9V

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name avzivi (source: ndc)
Generic Name bevacizumab-tnjn (source: ndc)
Application Number BLA761198 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 400 mg/16mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (82143-002-01) / 16 mL in 1 VIAL
source: ndc

Packages (1)

82143-002-01 1 VIAL in 1 CARTON (82143-002-01) / 16 mL in 1 VIAL

Ingredients (1)

bevacizumab-tnjn (400 mg/16mL)

Linked Drug Pages (1)

Avzivi tnjn, Avzivi ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "3fff12d3-d86b-14e4-e063-6294a90a122e", "openfda": {"unii": ["2S9ZZM9Q9V"], "rxcui": ["2700735", "2700742", "2700744", "2700745"], "spl_set_id": ["a3976cf9-9edb-4ca2-9375-9bcd2e32f5b4"], "manufacturer_name": ["Bio-Thera Solutions, Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (82143-002-01)  / 16 mL in 1 VIAL", "package_ndc": "82143-002-01", "marketing_start_date": "20250101"}], "brand_name": "Avzivi", "product_id": "82143-002_3fff12d3-d86b-14e4-e063-6294a90a122e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]", "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]"], "product_ndc": "82143-002", "generic_name": "bevacizumab-tnjn", "labeler_name": "Bio-Thera Solutions, Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Avzivi", "active_ingredients": [{"name": "BEVACIZUMAB-TNJN", "strength": "400 mg/16mL"}], "application_number": "BLA761198", "marketing_category": "BLA", "marketing_start_date": "20250101", "listing_expiration_date": "20261231"}